505 related articles for article (PubMed ID: 15901957)
1. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
2. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
3. Simple photodynamic therapy dose models fail to predict the survival of MLL cells after HPPH-PDT in vitro.
Weston MA; Patterson MS
Photochem Photobiol; 2009; 85(3):750-9. PubMed ID: 19140895
[TBL] [Abstract][Full Text] [Related]
4. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
5. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.
Yuan J; Mahama-Relue PA; Fournier RL; Hampton JA
Radiat Res; 1997 Oct; 148(4):386-94. PubMed ID: 9339955
[TBL] [Abstract][Full Text] [Related]
6. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
7. In vitro photodynamic activity of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) loaded-poly(lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells.
da Silva AR; Inada NM; Rettori D; Baratti MO; Vercesi AE; Jorge RA
J Photochem Photobiol B; 2009 Feb; 94(2):101-12. PubMed ID: 19070504
[TBL] [Abstract][Full Text] [Related]
8. Modeling of a type II photofrin-mediated photodynamic therapy process in a heterogeneous tissue phantom.
Hu XH; Feng Y; Lu JQ; Allison RR; Cuenca RE; Downie GH; Sibata CH
Photochem Photobiol; 2005; 81(6):1460-8. PubMed ID: 15960591
[TBL] [Abstract][Full Text] [Related]
9. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
10. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.
Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T
Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808
[TBL] [Abstract][Full Text] [Related]
11. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
Mitra S; Foster TH
Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
[TBL] [Abstract][Full Text] [Related]
12. Active oxygen intermediates in the degradation of hematoporphyrin derivative in tumor cells subjected to photodynamic therapy.
Chekulayeva LV; Chekulayev VA; Shevchuk IN
J Photochem Photobiol B; 2008 Nov; 93(2):94-107. PubMed ID: 18760622
[TBL] [Abstract][Full Text] [Related]
13. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
Qiu H; Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
[TBL] [Abstract][Full Text] [Related]
14. Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms.
Finlay JC; Mitra S; Patterson MS; Foster TH
Phys Med Biol; 2004 Nov; 49(21):4837-60. PubMed ID: 15584523
[TBL] [Abstract][Full Text] [Related]
15. Uptake of photofrin II, a photosensitizer used in photodynamic therapy, by tumour cells in vitro.
Chwiłkowska A; Saczko J; Modrzycka T; Marcinkowska A; Malarska A; Bielewicz J; Patalas D; Banaś T
Acta Biochim Pol; 2003; 50(2):509-13. PubMed ID: 12833175
[TBL] [Abstract][Full Text] [Related]
16. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro.
Sadzuka Y; Tokutomi K; Iwasaki F; Sugiyama I; Hirano T; Konno H; Oku N; Sonobe T
Cancer Lett; 2006 Sep; 241(1):42-8. PubMed ID: 16303246
[TBL] [Abstract][Full Text] [Related]
17. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
[TBL] [Abstract][Full Text] [Related]
19. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.
You Y; Gibson SL; Hilf R; Davies SR; Oseroff AR; Roy I; Ohulchanskyy TY; Bergey EJ; Detty MR
J Med Chem; 2003 Aug; 46(17):3734-47. PubMed ID: 12904078
[TBL] [Abstract][Full Text] [Related]
20. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells.
Cincotta L; Foley JW; Cincotta AH
Cancer Res; 1993 Jun; 53(11):2571-80. PubMed ID: 8495421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]